Filing Details

Accession Number:
0001144204-14-039881
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-26 18:02:31
Reporting Period:
2014-06-23
Filing Date:
2014-06-26
Accepted Time:
2014-06-26 18:02:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
868278 Prophase Labs Inc. PRPH Pharmaceutical Preparations (2834) 232577138
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457896 William Ted Karkus 621 N. Shady Retreat Road
Doylestown PA 18901
Ceo & Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0005 Acquisiton 2013-06-23 58,370 $1.51 1,722,958 No 4 P Direct
Common Stock, Par Value $0.0005 Acquisiton 2013-06-24 286,150 $1.56 2,009,108 No 4 P Direct
Common Stock, Par Value $0.0005 Acquisiton 2013-06-25 155,480 $1.58 2,164,588 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.57, inclusive.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.61, inclusive.